R1 RCM Inc. (NASDAQ:RCM) Holdings Decreased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. reduced its stake in shares of R1 RCM Inc. (NASDAQ:RCMGet Rating) by 13.1% during the first quarter, Holdings Channel.com reports. The firm owned 446,935 shares of the healthcare provider’s stock after selling 67,563 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in R1 RCM were worth $11,960,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Walleye Capital LLC raised its stake in shares of R1 RCM by 53.5% during the first quarter. Walleye Capital LLC now owns 320,697 shares of the healthcare provider’s stock valued at $8,582,000 after purchasing an additional 111,717 shares in the last quarter. Neuberger Berman Group LLC raised its stake in shares of R1 RCM by 117.6% during the first quarter. Neuberger Berman Group LLC now owns 897,400 shares of the healthcare provider’s stock valued at $24,014,000 after purchasing an additional 484,909 shares in the last quarter. Penn Capital Management Company LLC raised its stake in shares of R1 RCM by 15.1% during the first quarter. Penn Capital Management Company LLC now owns 470,899 shares of the healthcare provider’s stock valued at $12,809,000 after purchasing an additional 61,747 shares in the last quarter. Point72 Hong Kong Ltd raised its stake in shares of R1 RCM by 100.5% during the first quarter. Point72 Hong Kong Ltd now owns 4,203 shares of the healthcare provider’s stock valued at $112,000 after purchasing an additional 2,107 shares in the last quarter. Finally, Portolan Capital Management LLC bought a new stake in shares of R1 RCM during the first quarter valued at about $8,828,000. 49.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on RCM shares. KeyCorp started coverage on shares of R1 RCM in a research report on Thursday, September 15th. They issued an “overweight” rating and a $30.00 price target on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of R1 RCM from $26.00 to $31.00 in a research report on Thursday, August 4th. Truist Financial started coverage on shares of R1 RCM in a research report on Wednesday, September 7th. They issued a “buy” rating and a $29.00 price target on the stock. Barclays reiterated an “overweight” rating and issued a $29.00 price target on shares of R1 RCM in a research report on Wednesday, June 29th. Finally, JPMorgan Chase & Co. started coverage on shares of R1 RCM in a research report on Monday, August 1st. They issued an “overweight” rating on the stock. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, R1 RCM has an average rating of “Moderate Buy” and an average price target of $30.00.

Insider Buying and Selling

In other R1 RCM news, insider John M. Sparby sold 4,691 shares of R1 RCM stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $25.83, for a total transaction of $121,168.53. Following the transaction, the insider now owns 188,137 shares of the company’s stock, valued at approximately $4,859,578.71. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other R1 RCM news, insider John M. Sparby sold 4,691 shares of R1 RCM stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $25.83, for a total transaction of $121,168.53. Following the transaction, the insider now owns 188,137 shares of the company’s stock, valued at approximately $4,859,578.71. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider John M. Sparby sold 4,365 shares of R1 RCM stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $26.03, for a total value of $113,620.95. Following the transaction, the insider now directly owns 163,772 shares in the company, valued at approximately $4,262,985.16. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,449,056 shares of company stock valued at $317,717,189. 63.50% of the stock is owned by corporate insiders.

R1 RCM Trading Down 3.3 %

Shares of RCM opened at $20.18 on Tuesday. The business’s 50-day moving average price is $23.47 and its 200 day moving average price is $23.35. The stock has a market capitalization of $8.40 billion, a P/E ratio of 112.12, a P/E/G ratio of 4.68 and a beta of 0.95. R1 RCM Inc. has a 1-year low of $18.73 and a 1-year high of $27.86. The company has a current ratio of 1.57, a quick ratio of 1.54 and a debt-to-equity ratio of 0.64.

R1 RCM Company Profile

(Get Rating)

R1 RCM Inc provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers.

Further Reading

Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc. (NASDAQ:RCMGet Rating).

Institutional Ownership by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.